TrueLab TrueLab Care
Evidence reviews · DOI-cited sources · research use only

Research peptides, evidence, methods and laboratory practice

We read the papers and report what follows from them, along with what does not.

Evidence reviews & mechanisms

The Science

View all →

Research 15 November 2026

TRIUMPH-2: retatrutide in type 2 diabetes, and why the numbers are smaller

The second pivotal trial moved the compound into a harder population: adults with obesity who also have type 2 diabetes. The weight figures are lower than in TRIUMPH-1, and that gap is not a disappointment. It is the single most consistent finding in the entire incretin class.

3 min read · 4 sources

Research 13 November 2026

The peptide that came out of a lizard: how exendin-4 started the incretin class

Every weekly GLP-1 injection on the market descends from a molecule found in the saliva of a venomous desert lizard in 1992. The story is usually told as a curiosity. It is better told as a case study in how a research observation becomes a drug, and how long that takes.

3 min read · 3 sources

Research 7 November 2026

TRIUMPH-1: what the first phase 3 retatrutide trial actually measured

The phase 2 record for retatrutide was 338 people over 48 weeks. TRIUMPH-1 is 2,339 people over 80 weeks, peer-reviewed in the New England Journal of Medicine. This is the trial that moves the compound from a promising signal to a registration dossier, and the numbers deserve a closer read than the headline.

4 min read · 4 sources

Research 5 November 2026

CJC-1295 vs ipamorelin: two receptors compared side by side

These two are almost always discussed as a pair, and unusually the pairing has a real basis, they act through different receptors, so combining them is a coherent design rather than doubling up. But one of them has a naming problem serious enough that the trial data people quote may not describe the material they are holding.

3 min read · 3 sources

Reconstitution, storage & methods

The Lab

View all →

How these pieces are written

Every figure is cited

Every number comes from a published study and carries a DOI link. Figures are reused only from openly licensed papers, always with a credit line.

Including what is not known

We state where the evidence stops, how many studies ran in humans versus animals, and what a given paper does not settle.

Not medical advice

We describe these materials as reagents for in-vitro laboratory research. We do not suggest any use in humans or animals.